MannKind Announces Enrollment Goal Completion of INHALE-1 Pe

Reached enrollment goal of 305 patients living with Type 1 or Type 2 diabetesPrimary endpoint analysis expected in 4Q 2024Data dissemination and FDA submission expected in 2025

Related Keywords

Kevin Kaiserman , Lori Laffel , Rose Alinaya , Christie Iacangelo , Corporate Communications , Facebook , Professor Of Pediatrics At Harvard Medical School , Young Adult Section At Joslin Diabetes Center , Linkedin , Affairs For Mannkind Corporation , Exchange Commission , Mannkind Corporation , Clinical Development , Mannkind Corporation Nasdaq , Kind Corporation , Young Adult Section , Joslin Diabetes Center , Harvard Medical , Senior Vice President , Medical Affairs , Annual Report , Investor Relations , Region ,